Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Pegloticase Tumor Lysis Syndrome	M.D. Anderson Cancer Center	P4	BB (69)
Phentermine Essential Hypertension	VIVUS LLC	P4	BB (69)
Phenytoin Traumatic Brain Injury	All India Institute of Medical Sciences, Jodhpur	P4	BB (69)
Phytonadione, (E)-(±)- Esophageal Varices With Bleeding	Tanta University	P4	BB (69)
Piflufolastat Prostate Cancer	Novartis Pharmaceuticals	P4	BB (69)
Pioglitazone Metabolic Dysfunction-Associated Steatotic Liver Disease	Badr University	P4	BB (69)
Ppsv23 Pneumococcal Infection	Poitiers University Hospital	P4	BB (69)
Pramipexole Depressive Disorder	University of California, San Francisco	P4	BB (69)
Prednisone Chemotherapy-Induced Toxicity	Instituto do Cancer do Estado de São Paulo	P4	BB (69)
Prednisone Lung Cancer	Pfizer	P4	BB (69)
Prednisone Multiple Sclerosis	Holy Name Medical Center, Inc.	P4	BB (69)
Propofol Lung Cancer	Kaohsiung Medical University Chung-Ho Memorial Hospital	P4	BB (69)
Propofol Cancer	Hong Kong Children's Hospital	P4	BB (69)
Propofol Colorectal Cancer	Fudan University	P4	BB (69)
Propofol Gastric Ulcer	RenJi Hospital	P4	BB (69)
Propofol Gastrointestinal Polyp	RenJi Hospital	P4	BB (69)
Propofol Cardiovascular Disorder	Helse Fonna	P4	BB (69)
Propofol Delirium	RenJi Hospital	P4	BB (69)
Propofol Renal Cell Carcinoma	Seoul National University Hospital	P4	BB (69)
Quadrivalent Inactivated Influenza Vaccine Relapsing-Remitting Multiple Sclerosis	Novartis Pharmaceuticals	P4	BB (69)
Quetiapine Bipolar Disorder	First Affiliated Hospital of Zhejiang University	P4	BB (69)
Regorafenib Colorectal Neoplasm	Sergey Orlov, MD	P4	BB (69)
Remimazolam Osteoarthritis, Hip	Seoul National University Hospital	P4	BB (69)
Remimazolam Osteoarthritis, Knee	Seoul National University Hospital	P4	BB (69)
Remimazolam Bipolar Disorder	Yeongseok Yun	P4	BB (69)

Showing 2976 to 3000 of 42,286 assets

PreviousPage 120 of 1692Next